Article | May 19, 2021

Pandemic Demand Forces Rapidly Increased Production And Expertise

Source: Cytiva

To combat COVID-19, the life sciences industry rapidly changed its pace. Solis BioDyne, one of the leading reagent suppliers in Europe, manufactures PCR/qPCR reagents and specifically a ribonuclease inhibitor used for COVID-19 RT-qPCR diagnostic tests. Previously manufactured at bench scale, the company now needed to quickly increase production 50-fold to meet the demand of COVID-19 tests. Solis BioDyne faced two challenges: safely producing this large volume and maintaining a very high quality.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online